211 related articles for article (PubMed ID: 32727073)
1. Modeling of Frontotemporal Dementia Using iPSC Technology.
Kim M; Kim HJ; Koh W; Li L; Heo H; Cho H; Lyoo CH; Seo SW; Kim EJ; Nakanishi M; Na DL; Song J
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727073
[TBL] [Abstract][Full Text] [Related]
2. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells.
Lines G; Casey JM; Preza E; Wray S
Mol Cell Neurosci; 2020 Dec; 109():103553. PubMed ID: 32956830
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations.
Zhang Z; Almeida S; Lu Y; Nishimura AL; Peng L; Sun D; Wu B; Karydas AM; Tartaglia MC; Fong JC; Miller BL; Farese RV; Moore MJ; Shaw CE; Gao FB
PLoS One; 2013; 8(10):e76055. PubMed ID: 24143176
[TBL] [Abstract][Full Text] [Related]
4. MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations.
Biswas MHU; Almeida S; Lopez-Gonzalez R; Mao W; Zhang Z; Karydas A; Geschwind MD; Biernat J; Mandelkow EM; Futai K; Miller BL; Gao FB
Stem Cell Reports; 2016 Sep; 7(3):316-324. PubMed ID: 27594586
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
[TBL] [Abstract][Full Text] [Related]
6. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.
Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G
Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282
[TBL] [Abstract][Full Text] [Related]
7. Distinct Neurodegenerative Changes in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia Linked to Mutant TAU Protein.
Ehrlich M; Hallmann AL; Reinhardt P; Araúzo-Bravo MJ; Korr S; Röpke A; Psathaki OE; Ehling P; Meuth SG; Oblak AL; Murrell JR; Ghetti B; Zaehres H; Schöler HR; Sterneckert J; Kuhlmann T; Hargus G
Stem Cell Reports; 2015 Jul; 5(1):83-96. PubMed ID: 26143746
[TBL] [Abstract][Full Text] [Related]
8. Frontotemporal dementia.
Perry DC; Miller BL
Semin Neurol; 2013 Sep; 33(4):336-41. PubMed ID: 24234354
[TBL] [Abstract][Full Text] [Related]
9. Neuropathological background of phenotypical variability in frontotemporal dementia.
Josephs KA; Hodges JR; Snowden JS; Mackenzie IR; Neumann M; Mann DM; Dickson DW
Acta Neuropathol; 2011 Aug; 122(2):137-53. PubMed ID: 21614463
[TBL] [Abstract][Full Text] [Related]
10. Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability.
Silva MC; Cheng C; Mair W; Almeida S; Fong H; Biswas MHU; Zhang Z; Huang Y; Temple S; Coppola G; Geschwind DH; Karydas A; Miller BL; Kosik KS; Gao FB; Steen JA; Haggarty SJ
Stem Cell Reports; 2016 Sep; 7(3):325-340. PubMed ID: 27594585
[TBL] [Abstract][Full Text] [Related]
11. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia.
Prudencio M; Humphrey J; Pickles S; Brown AL; Hill SE; Kachergus JM; Shi J; Heckman MG; Spiegel MR; Cook C; Song Y; Yue M; Daughrity LM; Carlomagno Y; Jansen-West K; de Castro CF; DeTure M; Koga S; Wang YC; Sivakumar P; Bodo C; Candalija A; Talbot K; Selvaraj BT; Burr K; Chandran S; Newcombe J; Lashley T; Hubbard I; Catalano D; Kim D; Propp N; Fennessey S; ; Fagegaltier D; Phatnani H; Secrier M; Fisher EM; Oskarsson B; van Blitterswijk M; Rademakers R; Graff-Radford NR; Boeve BF; Knopman DS; Petersen RC; Josephs KA; Thompson EA; Raj T; Ward M; Dickson DW; Gendron TF; Fratta P; Petrucelli L
J Clin Invest; 2020 Nov; 130(11):6080-6092. PubMed ID: 32790644
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein.
Hallmann AL; Araúzo-Bravo MJ; Mavrommatis L; Ehrlich M; Röpke A; Brockhaus J; Missler M; Sterneckert J; Schöler HR; Kuhlmann T; Zaehres H; Hargus G
Sci Rep; 2017 Mar; 7():42991. PubMed ID: 28256506
[TBL] [Abstract][Full Text] [Related]
13. Pathological Progression Induced by the Frontotemporal Dementia-Associated R406W Tau Mutation in Patient-Derived iPSCs.
Nakamura M; Shiozawa S; Tsuboi D; Amano M; Watanabe H; Maeda S; Kimura T; Yoshimatsu S; Kisa F; Karch CM; Miyasaka T; Takashima A; Sahara N; Hisanaga SI; Ikeuchi T; Kaibuchi K; Okano H
Stem Cell Reports; 2019 Oct; 13(4):684-699. PubMed ID: 31543469
[TBL] [Abstract][Full Text] [Related]
14. Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.
Sposito T; Preza E; Mahoney CJ; Setó-Salvia N; Ryan NS; Morris HR; Arber C; Devine MJ; Houlden H; Warner TT; Bushell TJ; Zagnoni M; Kunath T; Livesey FJ; Fox NC; Rossor MN; Hardy J; Wray S
Hum Mol Genet; 2015 Sep; 24(18):5260-9. PubMed ID: 26136155
[TBL] [Abstract][Full Text] [Related]
15. Behavioural variant frontotemporal dementia--defining genetic and pathological subtypes.
Rohrer JD
J Mol Neurosci; 2011 Nov; 45(3):583-8. PubMed ID: 21559874
[TBL] [Abstract][Full Text] [Related]
16. Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation.
Su Y; Fu J; Yu J; Zhao Q; Guan Y; Zuo C; Li M; Tan H; Cheng X
J Alzheimers Dis; 2020; 76(1):149-157. PubMed ID: 32444551
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT).
Rasmussen MA; Hjermind LE; Hasholt LF; Waldemar G; Nielsen JE; Clausen C; Hyttel P; Holst B
Stem Cell Res; 2016 Jan; 16(1):70-4. PubMed ID: 27345788
[TBL] [Abstract][Full Text] [Related]
18. Temporal Variant Frontotemporal Dementia is Associated with Globular Glial Tauopathy.
Clark CN; Lashley T; Mahoney CJ; Warren JD; Revesz T; Rohrer JD
Cogn Behav Neurol; 2015 Jun; 28(2):92-7. PubMed ID: 26102999
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
[TBL] [Abstract][Full Text] [Related]
20. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS.
Chatterjee M; Özdemir S; Fritz C; Möbius W; Kleineidam L; Mandelkow E; Biernat J; Doğdu C; Peters O; Cosma NC; Wang X; Schneider LS; Priller J; Spruth E; Kühn AA; Krause P; Klockgether T; Vogt IR; Kimmich O; Spottke A; Hoffmann DC; Fliessbach K; Miklitz C; McCormick C; Weydt P; Falkenburger B; Brandt M; Guenther R; Dinter E; Wiltfang J; Hansen N; Bähr M; Zerr I; Flöel A; Nestor PJ; Düzel E; Glanz W; Incesoy E; Bürger K; Janowitz D; Perneczky R; Rauchmann BS; Hopfner F; Wagemann O; Levin J; Teipel S; Kilimann I; Goerss D; Prudlo J; Gasser T; Brockmann K; Mengel D; Zimmermann M; Synofzik M; Wilke C; Selma-González J; Turon-Sans J; Santos-Santos MA; Alcolea D; Rubio-Guerra S; Fortea J; Carbayo Á; Lleó A; Rojas-García R; Illán-Gala I; Wagner M; Frommann I; Roeske S; Bertram L; Heneka MT; Brosseron F; Ramirez A; Schmid M; Beschorner R; Halle A; Herms J; Neumann M; Barthélemy NR; Bateman RJ; Rizzu P; Heutink P; Dols-Icardo O; Höglinger G; Hermann A; Schneider A
Nat Med; 2024 Jun; 30(6):1771-1783. PubMed ID: 38890531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
